Dr. Lal PathLabs Limited (BOM:539524)
2,762.65
+34.30 (1.26%)
At close: Apr 22, 2025
Dr. Lal PathLabs Statistics
Total Valuation
BOM:539524 has a market cap or net worth of INR 232.33 billion. The enterprise value is 223.39 billion.
Market Cap | 232.33B |
Enterprise Value | 223.39B |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | Feb 5, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.16% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 37.07M |
Valuation Ratios
The trailing PE ratio is 55.74.
PE Ratio | 55.74 |
Forward PE | n/a |
PS Ratio | 9.66 |
PB Ratio | 11.42 |
P/TBV Ratio | 19.79 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 53.59 |
EV / Sales | 9.29 |
EV / EBITDA | 33.50 |
EV / EBIT | 42.03 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.10 |
Debt / EBITDA | 0.30 |
Debt / FCF | n/a |
Interest Coverage | 22.28 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 15.31% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 5.87M |
Profits Per Employee | 1.02M |
Employee Count | 4,099 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.94% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +22.94% |
50-Day Moving Average | 2,575.62 |
200-Day Moving Average | 2,980.20 |
Relative Strength Index (RSI) | 65.16 |
Average Volume (20 Days) | 25,292 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:539524 had revenue of INR 24.04 billion and earned 4.17 billion in profits. Earnings per share was 50.01.
Revenue | 24.04B |
Gross Profit | 13.88B |
Operating Income | 5.32B |
Pretax Income | 5.91B |
Net Income | 4.17B |
EBITDA | 6.29B |
EBIT | 5.32B |
Earnings Per Share (EPS) | 50.01 |
Balance Sheet
The company has 11.27 billion in cash and 1.99 billion in debt, giving a net cash position of 9.28 billion.
Cash & Cash Equivalents | 11.27B |
Total Debt | 1.99B |
Net Cash | 9.28B |
Net Cash Per Share | n/a |
Equity (Book Value) | 20.35B |
Book Value Per Share | 240.44 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 57.71%, with operating and profit margins of 22.11% and 17.34%.
Gross Margin | 57.71% |
Operating Margin | 22.11% |
Pretax Margin | 24.59% |
Profit Margin | 17.34% |
EBITDA Margin | 26.17% |
EBIT Margin | 22.11% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 0.87%.
Dividend Per Share | 24.00 |
Dividend Yield | 0.87% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -0.16% |
Shareholder Yield | 0.71% |
Earnings Yield | 1.79% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |